Filana Therapeutics (FLNA)'s 30-day implied volatility (IV30) was 113.7% at the close on October 16, 2026, up from 100.3% the day before, against a 52-week range of 43.2% to 400.0%. Its 20-day historical volatility was 98.2%.
Data as of October 16, 2026.